It was suggested that a cancer stem cell-like population isolated from a PANC1 cell line displayed divergent UPR responses after treatment with gemcitabine, where phospho-PERK and ATF6N were increased, and phospho-IRE1 was decreased [93]. Here, EIF2AK3 is linked to cancer.